These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1311962)

  • 21. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
    Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
    S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased prevalence of HCV antibodies in dialyzed Ashkenazi Jews--a possible ethnic predisposition.
    Golan E; Korzets Z; Cristal-Lilov A; Ben-Tovim T; Bernheim J
    Nephrol Dial Transplant; 1996 Apr; 11(4):684-6. PubMed ID: 8671859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis-C virus (HCV) in peritoneal dialysis.
    Krautzig S; Tillmann H; Wrenger E; Manns M; Koch KM; Brunkhorst R
    Clin Nephrol; 1994 Feb; 41(2):120. PubMed ID: 7516274
    [No Abstract]   [Full Text] [Related]  

  • 24. The need for second-generation antihepatitis C virus testing in uremic patients on continuous ambulatory peritoneal dialysis.
    Ng YY; Lee SD; Wu SC; Liu WT; Chia WL; Huang TP
    Perit Dial Int; 1993; 13(2):132-5. PubMed ID: 7684259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of antihepatitis C antibodies in patients treated with continuous ambulatory peritoneal dialysis and hemodialysis.
    Pérez-Fontán M; Moncalián J; Rodríguez-Carmona A; Arrojo F
    Nephron; 1991; 58(3):381-2. PubMed ID: 1654529
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis C antibodies in dialysis patients and patients with leukaemia.
    Kolho E; Oksanen K; Honkanen E; Naukkarinen R; Krusius T
    J Med Virol; 1993 Aug; 40(4):318-21. PubMed ID: 8228923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infection by hepatitis C virus in patients on hemodialysis: prevalence and risk factors].
    Leão JR; Pace FH; Chebli JM
    Arq Gastroenterol; 2010; 47(1):28-34. PubMed ID: 20520972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
    González-Michaca L; Mercado A; Gamba G
    Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C infection in a pediatric dialysis population.
    Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y
    Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus infection in renal dialysis patients in Glasgow.
    McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
    Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
    Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M
    Nephron; 1992; 61(3):346. PubMed ID: 1323786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzymed-linked immunosorbent assay.
    Schlipköter U; Gladziwa U; Cholmakov K; Weise A; Rasshofer R; Lorbeer B; Luz N; Deinhardt F; Roggendorf M
    Med Microbiol Immunol; 1992; 181(3):173-80. PubMed ID: 1381808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit.
    Lin HH; Huang CC; Sheen IS; Lin DY; Liaw YF
    Am J Nephrol; 1991; 11(3):192-4. PubMed ID: 1660221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of anti-HCV in patients on long-term hemodialysis.
    Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
    González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
    Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland.
    Conlon PJ; Walshe JJ; Smyth EG; McNamara EB; Donohoe J; Carmody M
    Ir J Med Sci; 1993 Apr; 162(4):145-7. PubMed ID: 7685747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.